 |
 |
Eight new islet cell transplantation centers to open internationally
The Juvenile Diabetes Foundation announced
at the annual meeting of the American Society of Transplantation in Chicago
that with its funding, eight new centers for human islet cell transplantation
research are opening in North America and Europe.
The Foundation has granted more than $10 million to
establish the centers, which will be located at Harvard (at the Joslin
Diabetes Center), the University of Miami, the University of Minnesota,
Washington University, Pacific Northwest Research Institute, the University
of Alberta, Canada, Vrije Universiteit in Brussels, Belgium, and the University
of Giessen, Germany.
Juvenile Diabetes Foundation vice president for research
Dr. Robert A. Goldstein noted that a major obstacle in islet cell transplantation
research has been a shortage of islet cells. ”The result was that laboratory
research was limited and clinical trials of islets cells were few and
far between. The new centers will help break through these barriers,”
Dr. Goldstein told the American Society for Transplantation.
Dr. Goldstein added that ”by developing common quality standards for islet
cells that meet FDA regulations, the centers make it easier for one laboratory
to prepare islets another laboratory can use.”
All of the centers are about to begin clinical trials of islet cell
transplantation, the Juvenile Diabetes Foundation announced.
Red
|